ArticleThoracic cancer2020

Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma.

Hai-Bo QiuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.